Daré will host a conference call and live webcast today, May 13, 2025, at 4:30 p.m. Eastern Time to review financial results ...

Agenus Inc (AGEN) reports a narrowed net loss and strategic advancements despite revenue decline and cash pressure in Q1 2025 ...

Sangamo Therapeutics Inc (SGMO) secures a major deal with Eli Lilly and advances its pipeline, while navigating funding needs ...

Resolutions have decriminalized psilocybin in cities across Western Washington. Studies show psychedelics can help people suffering from trauma, depression, and anxiety. And more people are ...

Q1 2025 Earnings Call Transcript May 12, 2025 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, ...

Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsBrian Luque - Head of Investor Relations ...

Meaningful extension of cash runway guidance from H2 2027 to H2 2028 following strategic decision to pursue partnership opportunities for naporafenib SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Erasca ...

The FDA will issue a decision on the BLA for RGX-121 by November, which if positive, could make it the first gene therapy for Hunter syndrome.

Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients) The Phase 2 st ...

Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now esti ...

Q1 2025 Earnings Call Transcript May 11, 2025 Operator: Greetings, and welcome to KORU Medical Systems First Quarter 2025 ...

Apple is reportedly developing brain-computer interface technology to allow users to control devices with thoughts, enhancing ...